1,084 results on '"Roccaro A. M."'
Search Results
2. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
3. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis
4. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
5. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
6. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
7. Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
8. Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
9. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88
10. Progression signature underlies clonal evolution and dissemination of multiple myeloma
11. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
12. Waking up exhausted BCMA-specific T cells in myeloma
13. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia
14. Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
15. Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
16. Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time
17. Genomic Aberrations in Multiple Myeloma
18. Epigenetics in Multiple Myeloma
19. Molecular Pathways in Growth and Survival: Epigenomics
20. Prognostic role of circulating exosomal miRNAs in multiple myeloma
21. Vascular and Stromal Contributions to Tumor Bone-Homing: Focus on Multiple Myeloma
22. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression
23. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche
24. Targeting SDF-1 in multiple myeloma tumor microenvironment
25. Epigenomics in Waldenstrom's macroglobulinaemia
26. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
27. Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis
28. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
29. Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma
30. Starving multiple myeloma cells via CDK7 inhibition
31. Data from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
32. Supplementary Methods from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
33. Supplementary Figures 1-15, Supplementary Table 1 from ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
34. Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
35. Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
36. Supplementary Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
37. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
38. CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
39. The cancer glycome: Carbohydrates as mediators of metastasis
40. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
41. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing
42. The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma
43. Bortezomib in Waldenstrom’s Macroglobulinemia
44. Fig S6 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
45. Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
46. Supplementary Table 1 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
47. Supplementary Data from FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
48. Supplementary Table Legend from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
49. Supplementary Figure Legend from Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
50. Supplementary Table from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.